Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- Device: Reprieve System
- First Posted Date
- 2025-03-27
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 400
- Registration Number
- NCT06898515
- Locations
- 🇺🇸
UH Cleveland Medical Center, Cleveland, Ohio, United States
🇺🇸University of California Irvine, Irvine, California, United States
🇺🇸Trinity Health Ann Arbor Hospital, Ann Arbor, Michigan, United States
EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- Drug: Diuretic (furosemide, bumetanide, torsemide, hydrochlorothiazide, and/or acetazolamide)Device: Reprieve Decongestion Management System
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 12
- Registration Number
- NCT06362668
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇵🇱Wroclaw Medical University, Wrocław, Poland
Reprieve System Pilot Study
- Conditions
- Acute Decompensated Heart Failure
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 50
- Registration Number
- NCT06272734
- Locations
- 🇬🇪
Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- Device: Reprieve Decongestion Management SystemDrug: Diuretic
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2025-07-24
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 100
- Registration Number
- NCT05174312
- Locations
- 🇺🇸
Eastern Shore Research Institute, Fairhope, Alabama, United States
🇺🇸University of California Irvine, Irvine, California, United States
🇺🇸Trinity Health Ann Arbor Hospital, Ypsilanti, Michigan, United States
Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study
- Conditions
- Heart Failure
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 31
- Registration Number
- NCT05015764
- Locations
- 🇬🇪
Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi, Georgia